May 2, 2024 · Form 4 insider transaction
Bhatia Sangeeta N. sold 467 shares of Vertex Pharmaceuticals Incorporated at $402.95 per share, a transaction worth $188.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/10/2023.